Hormonal Imbalance as a Driver of Hidradenitis Suppurativa
Many patients notice that HS flares follow a pattern — worsening before menstruation, during periods of stress, or when weight fluctuates. This is not coincidence. Hormonal activity directly influences the follicular environment in which HS develops, determining how much sebum the follicle produces, how prone it is to occlusion, and how aggressively the immune system responds when the follicle is disrupted. Hormonal correction is not peripheral to HS treatment — it is central.
Why Hormones Matter More Than Most HS Patients Are Told
AyurvedaPitta-Meda · Artava DushtiThe relationship between hormones and HS is well documented — yet it is rarely addressed in standard management beyond suggesting oral contraceptives or anti-androgens as symptom suppressants. Understanding what is actually happening hormonally clarifies why these interventions provide limited long-term benefit.
Androgens and the Follicular Environment
Androgens — a class of hormones that includes testosterone, DHT, and DHEA-S — regulate the activity of oil-producing glands (sebaceous glands) and influence how the cells lining hair follicles behave. When androgen activity is elevated, sebaceous glands produce more sebum; the follicular lining produces excess keratin; and the follicular opening becomes progressively narrower. In areas with high follicular density and apocrine gland concentration — underarms, groin, perineum, under the breasts — these effects are amplified by anatomical factors, making occlusion far more likely.
Androgen excess does not only mean abnormally high hormone levels in isolation. It also includes increased sensitivity of the follicular receptors to normal hormone levels — a pattern seen in many HS patients whose laboratory hormonal values appear within normal range. The follicle is responding disproportionately even when levels are not dramatically elevated.
Insulin Resistance — The Hidden Hormonal Link
Insulin resistance — a state where cells respond inadequately to insulin, requiring higher circulating levels — is deeply interconnected with androgen excess. Elevated insulin directly stimulates androgen production in the ovaries and adrenal glands; it also reduces the production of sex hormone-binding globulin (SHBG), which normally keeps androgen activity in check. The result is a self-reinforcing hormonal environment where elevated insulin sustains androgen excess, which sustains follicular occlusion, which sustains the HS cycle. This is why dietary patterns, metabolic health, and weight all influence HS severity — they are not peripheral lifestyle factors. They are direct modulators of the hormonal environment.
This is also why HS frequently overlaps with PCOS — a condition defined by exactly this combination of androgen excess, insulin resistance, and disrupted hormonal regulation. When PCOS is present and unaddressed, HS treatment focused only on the skin or on antibiotic suppression is working against a continuously active hormonal driver.
How Hormonal Imbalance Translates to HS — Step by Step
The connection between hormones and skin lesions is not immediate or simple. It involves a cascade of effects that explains both the predictable timing of HS flares and the progressive nature of the disease when the hormonal driver is not corrected.
Elevated Androgen Activity — The Starting Point
Whether driven by intrinsic overproduction, insulin resistance, adrenal dysregulation, or receptor hypersensitivity, the starting point is elevated effective androgen activity in the susceptible tissue. This creates a hormonal environment that predisposes certain follicles to dysfunction — specifically those in apocrine-rich areas where androgen receptors are highly expressed. The elevation may be consistent, or it may fluctuate — peaking premenstrually in women, for example, which explains the temporal association many patients observe between their hormonal cycle and HS flaring.
Sebaceous Hyperactivity and Follicular Crowding
Elevated androgen signalling increases sebaceous gland activity — producing more sebum than the follicular opening can effectively drain. Simultaneously, androgen-driven keratinocyte proliferation in the follicular lining produces excess keratin. The combination of increased sebum production and excess cellular material rapidly narrows the follicular canal. This is not a hygiene problem: it occurs in structurally normal follicles under the influence of a hormonal signal they are receiving continuously from the bloodstream. External cleansing has no meaningful impact on this process.
Occlusion and Pressure Buildup
As the follicular opening narrows and the canal fills with accumulated sebum and keratin, intrafollicular pressure increases. The sealed follicle becomes an environment increasingly prone to rupture. Commensal bacteria — organisms normally present on the skin surface without causing disease — multiply within this closed space, not because of infection introduced from outside, but because the environment has changed to support their proliferation. This distinction matters: the bacterial component is secondary to the structural and hormonal disruption, not its primary cause.
Immune Response and Lump Formation
The occluded follicle triggers a local immune response that is, in HS patients, characteristically amplified. Rather than a contained, resolving inflammatory reaction, the response escalates — producing the painful, deeply-seated nodule that patients experience. This amplification is partly a consequence of the hormonal environment itself: androgens modulate immune signalling, and chronic androgen excess alters the inflammatory threshold in susceptible tissue. The lump is the intersection of a structural event (follicular occlusion) and an immune-inflammatory response shaped by the hormonal background.
Recurrence — The Hormonal Driver Persists
When the hormonal environment remains uncorrected, the conditions that produced the initial occlusion regenerate continuously. Each hormonal cycle creates a new opportunity for follicular crowding; each period of elevated androgen activity — stress-induced, diet-driven, or cycle-related — is a recurrence trigger. This explains a pattern observed consistently: patients who respond transiently to antibiotics or hormonal suppressants relapse when treatment stops, because the underlying hormonal architecture has not changed. Long-term interruption of the cycle requires correcting the endocrine environment that is sustaining it.
In Ayurveda, hormonal imbalance in the context of HS is understood as disruption within the body's regulatory channels — affecting both the quality of metabolised substances circulating in the body and the stability of the internal regulatory system (equivalent to the endocrine-metabolic axis). When this regulation is disturbed, the tissues most sensitive to hormonal signals become the primary sites of dysfunction. The Ayurvedic approach to correction focuses on restoring the underlying regulatory stability rather than directly suppressing the visible hormonal excess.
"The goal is not just to control symptoms, but to understand why the condition is occurring in the first place."
Three Patient Patterns Where Hormonal Imbalance Is the Central Driver
Hormonal involvement in HS does not look the same across all patients. These are the three most commonly observed clinical patterns where hormonal dysregulation is the dominant driver — each with a distinct presentation and correction requirement.
HS With Concurrent PCOS — Shared Root, Amplified Disease
In women with diagnosed or undiagnosed PCOS, HS tends to present at multiple sites simultaneously, flares reliably in the premenstrual phase, and responds poorly to antibiotic courses. The overlap reflects a shared biological driver: androgen excess combined with insulin resistance. Neither condition can be effectively managed while the other goes uncorrected. Hormonal evaluation in these cases almost always reveals a pattern that extends well beyond the HS presentation itself — irregular cycles, acne, hirsutism, and metabolic markers that point to a systemic endocrine disruption rather than an isolated skin condition.
HS With Insulin Resistance — Dietary and Metabolic Involvement
In patients — both male and female — where insulin resistance is the primary hormonal driver, HS severity correlates strongly with dietary patterns and metabolic health indicators. These patients often report worsening after high-carbohydrate periods, improvement when dietary patterns shift toward lower glycaemic load, and a disease course that has progressively worsened alongside metabolic changes such as weight gain or blood sugar dysregulation. Correction in these cases requires addressing insulin sensitivity as a foundational component of HS treatment — not as a separate health issue to be managed independently.
HS That Reliably Worsens Under Stress — Adrenal Axis Involvement
In some patients, the dominant hormonal driver is adrenal — elevated cortisol and adrenal androgen output during periods of chronic or acute stress. These patients notice a clear and consistent relationship between stressful periods and HS flares, often initially attributed to "stress lowering immunity." The mechanism is more specific: elevated stress hormones directly stimulate androgen output and amplify inflammatory signalling. Adrenal dysregulation as an HS driver is distinct from PCOS-linked patterns and requires a correction approach that addresses the stress-cortisol-androgen axis rather than reproductive hormones alone.
Factors That Amplify Hormonal Disruption in HS
Hormonal imbalance in HS is rarely a static, unchanging state. Certain conditions and patterns consistently amplify the hormonal driver — increasing flare frequency and severity, and widening the gap between what treatment can achieve and what the body is actually doing internally.
High Glycaemic Dietary Patterns
Diets high in refined carbohydrates and sugar drive repeated insulin spikes, which directly stimulate androgen production and reduce the proteins that regulate androgen activity. This creates a dietary-hormonal feedback loop that actively sustains the HS environment. The relationship is dose-dependent: the more consistent and prolonged the dietary pattern, the more established the hormonal disruption becomes.
Chronic Sleep Disruption
Sleep is when hormonal regulation — including cortisol, growth hormone, and reproductive hormones — undergoes its critical overnight cycle. Consistently disrupted or insufficient sleep desynchronises this cycle, elevating baseline cortisol and amplifying adrenal androgen output. For HS patients, sleep quality is not a peripheral wellness consideration: it is a direct modulator of the hormonal environment driving the disease.
Sustained Psychological Stress
The adrenal response to psychological stress produces cortisol and adrenal androgens — both of which contribute to the hormonal environment that sustains HS. Patients who experience sustained occupational, relational, or environmental stress often observe that their HS activity tracks with their stress levels in a way that feels undeniable. The mechanism is not vague: it is a direct hormonal pathway from stress perception to androgen output to follicular dysfunction.
Hormonal Contraceptives and Exogenous Hormones
Certain hormonal contraceptives — particularly those with progestins with androgenic activity — can worsen HS by adding to the androgenic burden. Conversely, some formulations with anti-androgenic progestins may reduce HS activity, but without addressing the underlying dysregulation. Exogenous hormone use also affects the liver's regulation of sex hormone-binding globulin, influencing how much free androgen circulates. Hormonal contraceptive choice requires specific consideration in the context of HS management.
What Correcting the Hormonal Driver Actually Involves
Why Suppression Is Not the Same as Correction
The standard hormonal interventions offered for HS — anti-androgens, combined oral contraceptives, or metformin for insulin resistance — work by suppressing individual hormonal signals rather than addressing the regulatory disruption that is generating them. They can reduce flare frequency while active, which is clinically useful; but they do not restore normal hormonal regulation, which is why HS typically returns to its previous pattern when these medications are discontinued. Correction — as distinct from suppression — requires identifying and addressing the underlying drivers of hormonal dysregulation.
Personalisation Is Essential — Hormonal Profiles Differ
The hormonal architecture of HS varies substantially between patients. A woman with PCOS-driven androgen excess requires a different approach than a man with insulin resistance-driven hormonal disruption, or a woman whose HS is primarily adrenal in origin. Treatment that addresses the specific hormonal pattern — rather than applying a standard anti-androgen protocol to all cases — produces meaningfully different outcomes. This is why personalised hormonal evaluation precedes all treatment decisions.
How treatment works →How Hormonal Imbalance Connects to the Broader HS Picture
Hormonal dysregulation in HS does not operate independently. It interacts with gut dysfunction, immune dysregulation, and metabolic disruption — each amplifying the others. Understanding these connections is essential to understanding why HS persists despite partial treatment.
Unless the Hormonal Driver Is Addressed, the Cycle Will Continue
A personalised evaluation identifies the specific hormonal pattern sustaining your HS — whether adrenal, ovarian, or metabolic — and what a structured approach to correcting it looks like. At this stage, understanding the hormonal architecture of your case is the most important information you can have.